136 related articles for article (PubMed ID: 12617890)
1. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
Donkor IO; Korukonda R; Huang TL; LeCour L
Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.
Donkor IO; Korukonda R
Bioorg Med Chem Lett; 2008 Sep; 18(17):4806-8. PubMed ID: 18694642
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
[TBL] [Abstract][Full Text] [Related]
4. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
5. P2-proline-derived inhibitors of calpain I.
Tripathy R; Gu ZQ; Dunn D; Senadhi SE; Ator MA; Chatterjee S
Bioorg Med Chem Lett; 1998 Oct; 8(19):2647-52. PubMed ID: 9873596
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
[TBL] [Abstract][Full Text] [Related]
7. Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents.
Tripathy R; Ator MA; Mallamo JP
Bioorg Med Chem Lett; 2000 Oct; 10(20):2315-9. PubMed ID: 11055346
[TBL] [Abstract][Full Text] [Related]
8. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues.
McConnell RM; York JL; Frizzell D; Ezell C
J Med Chem; 1993 Apr; 36(8):1084-9. PubMed ID: 8478905
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors.
Lubisch W; Hofmann HP; Treiber HJ; Möller A
Bioorg Med Chem Lett; 2000 Oct; 10(19):2187-91. PubMed ID: 11012026
[TBL] [Abstract][Full Text] [Related]
11. Poststatin, a new inhibitor of prolyl endopeptidase. V. Endopeptidase inhibitory activity of poststatin analogues.
Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
J Antibiot (Tokyo); 1996 Sep; 49(9):890-9. PubMed ID: 8931723
[TBL] [Abstract][Full Text] [Related]
12. Poststatin, a new inhibitor of prolyl endopeptidase. VII. N-cycloalkylamide analogues.
Tsuda M; Muraoka Y; Nagai M; Aoyagi T; Takeuchi T
J Antibiot (Tokyo); 1996 Sep; 49(9):909-20. PubMed ID: 8931725
[TBL] [Abstract][Full Text] [Related]
13. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome.
Mellgren RL
J Biol Chem; 1997 Nov; 272(47):29899-903. PubMed ID: 9368065
[TBL] [Abstract][Full Text] [Related]
14. New m-calpain substrate-based azapeptide inhibitors.
Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
16. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases.
Pliura DH; Bonaventura BJ; Smith RA; Coles PJ; Krantz A
Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):759-62. PubMed ID: 1471990
[TBL] [Abstract][Full Text] [Related]
17. Optimization of peptidyl allyl sulfones as clan CA cysteine protease inhibitors.
Fennell BD; Warren JM; Chung KK; Main HL; Arend AB; Tochowicz A; Götz MG
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):468-78. PubMed ID: 22380780
[TBL] [Abstract][Full Text] [Related]
18. Peptides containing acylated C-terminal gem diamines: novel irreversible inactivators of the cysteine and serine proteinases.
Gilmore BF; Lynas JF; Harriott P; Healy A; Walker B
Chem Biol Drug Des; 2006 May; 67(5):364-9. PubMed ID: 16784461
[TBL] [Abstract][Full Text] [Related]
19. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of potential thrombin inhibitors. Incorporation of tartaric acid templates as P2 proline mimetics.
Dahlgren A; Brånalt J; Kvarnström I; Nilsson I; Musil D; Samuelsson B
Bioorg Med Chem; 2002 May; 10(5):1567-80. PubMed ID: 11886818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
